Welcome to iCeutica

Focused on rapidly improving and launching reformulated pharmaceutical products.

iCeutica is developing new pharmaceutical products using its proprietary SoluMatrix™ reformulation platform. This platform enables it to make nano-sized particles of various approved drugs. In clinical trials to date, iCeutica’s SoluMatrix-reformulated drugs have been shown to dissolve much more quickly and provide the potential for significant patient benefits, compared to the currently marketed versions of the drugs.

iCeutica has reformulated a number of drugs using its SoluMatrix platform, including two drugs that are being prepared for Phase III clinical trials, one that is entering a Phase II clinical trial, and two entering Phase I trials. In addition iCeutica is developing a pipeline of new opportunities for near-term clinical development.

Our technology > Our team >